Cargando…
High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients
The impact of serum levels of soluble programmed cell death ligand 1 (sPD-L1) on prognosis in patients with Epstein-Barr virus-associated malignancies has never been investigated. We prospectively measured pre- and post-treatment serum sPD-L1 levels and evaluated their prognostic value in 97 patient...
Autores principales: | Wang, Hua, Wang, Liang, Liu, Wen-Jian, Xia, Zhong-Jun, Huang, Hui-Qiang, Jiang, Wen-Qi, Li, Zhi-Ming, Lu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078073/ https://www.ncbi.nlm.nih.gov/pubmed/27105512 http://dx.doi.org/10.18632/oncotarget.8847 |
Ejemplares similares
-
Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase
por: Wang, Liang, et al.
Publicado: (2015) -
Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type
por: Wang, Jing-hua, et al.
Publicado: (2017) -
Extranodal NK/T cell lymphoma
por: Jeong, Seong Hyun
Publicado: (2020) -
Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022) -
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
por: Kim, Seok Jin, et al.
Publicado: (2022)